PubRank

Nikolaos M Siafakas

Author PubWeight™ 83.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sleep patterns in patients with acute coronary syndromes. Sleep Med 2010 1.74
2 Is a miliary chest pattern always indicative of tuberculosis or malignancy? Respiration 2006 1.67
3 Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration 2005 1.44
4 Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology 2013 1.43
5 Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 2007 1.42
6 Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2007 1.41
7 Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 2004 1.39
8 Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005 1.39
9 Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis 2006 1.31
10 Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med 2005 1.26
11 Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med 2006 1.15
12 Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med 2012 1.14
13 Preventing exacerbations of COPD--advice from Hippocrates. N Engl J Med 2011 1.11
14 Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol 2006 1.10
15 Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006 1.02
16 Clinical presentation and management of empyema, lung abscess and pleural effusion. Curr Opin Pulm Med 2006 0.98
17 Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002 0.96
18 Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004 0.95
19 Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med 2004 0.94
20 The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest 2002 0.94
21 Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest 2005 0.93
22 Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol 2012 0.93
23 Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest 2009 0.93
24 Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res 2006 0.92
25 Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 2006 0.92
26 Smoking and pulmonary fibrosis: novel insights. Pulm Med 2011 0.92
27 Severe airway stenosis associated with Crohn's disease: case report. BMC Pulm Med 2006 0.92
28 Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002 0.91
29 Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir Res 2010 0.91
30 Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med 2004 0.90
31 Air travel for patients with chronic obstructive pulmonary disease: a case report. Br J Gen Pract 2012 0.90
32 Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther 2006 0.90
33 Asthma in the Elderly: Can We Distinguish It from COPD? J Allergy (Cairo) 2011 0.90
34 Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. Connect Tissue Res 2010 0.90
35 Biomarkers in COPD. Curr Med Chem 2007 0.89
36 Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2009 0.89
37 Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience. Pulm Pharmacol Ther 2011 0.89
38 Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med 2008 0.88
39 Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial. Eur Respir J 2011 0.88
40 C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest 2010 0.88
41 Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Respir Med 2010 0.88
42 Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol 2010 0.88
43 Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest 2009 0.87
44 Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). J Recept Signal Transduct Res 2010 0.87
45 Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm Pharmacol Ther 2008 0.87
46 Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest 2011 0.86
47 Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med 2007 0.86
48 Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series. J Med Case Rep 2011 0.86
49 Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS One 2011 0.85
50 Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 2010 0.84
51 Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest 2002 0.84
52 Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. BMC Pulm Med 2011 0.84
53 Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med 2005 0.84
54 DNA damage due to oxidative stress in Chronic Obstructive Pulmonary Disease (COPD). Int J Mol Sci 2012 0.83
55 Microsatellite DNA instability in benign lung diseases. Respir Med 2005 0.83
56 Translation and validation of Berlin questionnaire in primary health care in Greece. BMC Pulm Med 2013 0.83
57 Expression of FACIT collagens XII and XIV during bleomycin-induced pulmonary fibrosis in mice. Anat Rec A Discov Mol Cell Evol Biol 2003 0.82
58 Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions. Curr Drug Targets 2013 0.82
59 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest 2004 0.82
60 Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome. Hellenic J Cardiol 2006 0.82
61 Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med 2006 0.82
62 Lymphangiogenesis in COPD: another link in the pathogenesis of the disease. Respir Med 2011 0.82
63 The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications. Exp Ther Med 2010 0.81
64 Prediction of obstructive sleep apnea syndrome in a large Greek population. Sleep Breath 2010 0.81
65 Laser-assisted uvulopalatoplasty for the treatment of snoring and mild obstructive sleep apnea syndrome. J Otolaryngol 2003 0.81
66 Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial. Sleep Breath 2011 0.80
67 Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Pathol Res Pract 2008 0.80
68 Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer. J Recept Signal Transduct Res 2010 0.80
69 Somatic DNA alterations in lung epithelial barrier cells in COPD patients. Pulm Pharmacol Ther 2009 0.79
70 Airway inflammation and cellular stress in noneosinophilic atopic asthma. Chest 2006 0.79
71 Short telomeres and treatment of pulmonary fibrosis: implications for early intervention. Am J Respir Crit Care Med 2009 0.79
72 Laboratory markers for COPD in "susceptible" smokers. Clin Chim Acta 2005 0.79
73 A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration 2006 0.78
74 Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations. Respir Res 2006 0.78
75 Granule cytotoxic activity and oxidative DNA damage in smoking and nonsmoking patients with asthma. Chest 2013 0.78
76 Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP). Sarcoidosis Vasc Diffuse Lung Dis 2004 0.78
77 Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers. Mediators Inflamm 2010 0.78
78 Investigation of angiogenetic pathways in nasal polyposis. Mol Med Rep 2012 0.77
79 Erdheim-Chester disease: pulmonary presentation in a case with advanced systemic involvement. Respiration 2008 0.77
80 Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b. Sarcoidosis Vasc Diffuse Lung Dis 2005 0.77
81 Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction. Eur J Clin Invest 2013 0.77
82 Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis. BMC Pulm Med 2006 0.77
83 Perforin down-regulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and BAL study. Chest 2006 0.77
84 Active remodeling in idiopathic interstitial pneumonias: evaluation of collagen types XII and XIV. J Histochem Cytochem 2006 0.77
85 Molecular response of the human diaphragm on different modes of mechanical ventilation. Respiration 2012 0.77
86 Utility of formulas predicting the optimal nasal continuous positive airway pressure in a Greek population. Sleep Breath 2010 0.76
87 Gluteal adipose-tissue polyunsaturated fatty-acids profiles and depressive symptoms in obese adults with obstructive sleep apnea hypopnea syndrome: a cross-sectional study. Pharmacol Biochem Behav 2011 0.76
88 Acquired somatic mutations in the microsatellite DNA, in children with bronchial asthma. Pediatr Pulmonol 2009 0.76
89 Upregulation of stromal cell derived factor-1alpha in collagen vascular diseases-associated interstitial pneumonias (CVDs-IPs). Pulm Pharmacol Ther 2009 0.76
90 Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 0.76
91 A telehealth integrated asthma-COPD service for primary care: a proposal for a pilot feasibility study in Crete, Greece. BMC Res Notes 2010 0.75
92 Molecular pathological findings of Merkel cell polyomavirus in lung cancer: a possible etiopathogenetic link? Int J Cancer 2013 0.75
93 Induced sputum in interstitial lung diseases: novel insights in the diagnosis, evaluation and research. Respiration 2008 0.75
94 Comparison of induced sputum inflammatory profiles between childhood and adult-onset asthma. Respir Med 2006 0.75
95 Simultaneous existence of two different endobronchial disorders diagnosed by bronchoscopy. Respiration 2005 0.75
96 Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema. Pulm Pharmacol Ther 2005 0.75